by McKesson Ventures | Sep 19, 2023 | Press Releases
Evidation, a company focused on improving everyday health, has announced a partnership with USC’s Dornsife Center for Economic and Social Research to integrate wearable device data into their Understanding America Study (UAS). This collaboration aims to...
by McKesson Ventures | Sep 18, 2023 | Portfolio News
Deborah Kilpatrick is the co- CEO and Executive Chair of the Board for Evidation Health. In her role at Evidation, Deb aims to help individuals integrate health assessment data into their daily lives, taking control of their own health outside the doctor’s office. In...
by McKesson Ventures | May 25, 2023 | Portfolio News
Evidation and Myovant Sciences conducted a survey about the lived experiences of people with endometriosis and/or uterine fibroids. The results of that survey show the magnitude of the negative impacts these conditions have on employee and student experiences and...
by McKesson Ventures | Apr 20, 2023 | Portfolio News
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research...
by McKesson Ventures | Nov 15, 2021 | Portfolio News
Luca Foschini, PhD, is chief data scientist and co-founder at Evidation Health. In a recent interview he discussed how artificial intelligence interacts with patient-generated data to create advancements in clinical studies for pharmaceutical and biotech companies....
